Last reviewed · How we verify

NCT04426058

CMP vs Fascia Iliaca Block

Status unknown NA Last updated 20 April 2022
What this trial tests

NA trial testing CMP in Pain, Postoperative in 40 participants. Status unknown.

Timeline
6 June 2020
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorLoyola University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date6 June 2020
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Loyola University

Who can join

18 and older, any sex, with Pain, Postoperative or Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Complete motorsparing protocol (CMP) has been developed to try to minimize the motor nerve block that is created when using Facia iliaca nerve block. The blocks performed in the (CMP) are the cluneal nerve block, Pericapsular nerve group block and lateral femoral cutaneous block. On the clinical trial, the investigators will randomize the participants that meet criteria to CMP or Fascia iliaca Block and compare the amount of opioid needed post op during 24 hours and their pain scores.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Loyola University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04426058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing